Marktprognose für Fischimpfstoffe in Europa bis 2030 – regionale Analyse – nach Impfstofftyp (inaktivierte Impfstoffe, abgeschwächte Lebendimpfstoffe, Untereinheitenimpfstoffe, rekombinante Vektorimpfstoffe und andere), Anwendung (bakterielle Infektion, Virusinfektion und Parasit), Verabreichungsweg (Injektion). Impfstoff, Immersionsimpfstoff und oraler Impfstoff) und Arten (Lachs, Forelle, Tilapia und andere)
Die steigende Nachfrage nach aus Wassertieren gewonnenen Nahrungsmitteln treibt den europäischen Markt für Fischimpfstoffe an
Eine ungesunde Ernährung ist ein wachsendes Problem in Entwicklungs- und Industrieländern, was zu einer Vielzahl negativer gesundheitlicher Folgen führt. Daher ist Fisch in der Ernährung für ein gesundes Wachstum und eine gesunde Entwicklung äußerst empfehlenswert, da er reich an Vitaminen, Mineralien, Lipiden und Makronährstoffen wie Proteinen ist. Darüber hinaus wird davon ausgegangen, dass Aquakultur der effektivste Weg ist, hochwertige Proteine für eine nachhaltige menschliche Ernährung zu produzieren. Das wachsende Bewusstsein für die ernährungsphysiologischen Vorteile des Fischkonsums steigert die Nachfrage nach nachhaltigen, hochwertigen und gesunden Fleischprodukten. Daher treibt der steigende Konsum von Fisch und aus Fisch gewonnenen Produkten das Wachstum des Marktes für Fischimpfstoffe voran.
Marktübersicht für Fischimpfstoffe in Europa
Der europäische Markt für Fischimpfstoffe ist in Deutschland, das Vereinigte Königreich, Frankreich, Italien, Spanien und das übrige Europa unterteilt. Die Region hält einen bedeutenden Marktanteil auf dem Markt für Fischimpfstoffe. Es wird erwartet, dass der europäische Fischimpfstoffmarkt im Prognosezeitraum aufgrund von Faktoren wie dem erheblichen Wachstum in der Aquakulturindustrie, der steigenden Nachfrage nach aus Wassertieren gewonnenen Nahrungsmitteln und den wachsenden Forschungs- und Entwicklungsaktivitäten für die Entwicklung von Fischimpfstoffen durch Marktteilnehmer in deutliches Wachstum verzeichnen wird die Region. Die Aquakultur ist einer der wichtigsten Lebensmittelproduktionssektoren im Vereinigten Königreich. Nach Angaben des Ministeriums für Wirtschaft und Handel (UK) wird der Kauf von Meeresfrüchten in Großbritannien auf etwa 5,14 Milliarden US-Dollar geschätzt. Laut Innovate UK beträgt der Produktionswert der Aquakulturindustrie im Vereinigten Königreich etwa 730,88 US-Dollar pro Jahr. Um das Bewusstsein für die Bedeutung der Erhaltung von Aquakultur und Fischerei zu schärfen, werden von den Regulierungsbehörden verschiedene Veranstaltungen organisiert. Im Mai 2023 fand in Aviemore, Schottland, die größte Fachmesse Großbritanniens – Aquaculture UK – für die Aquakulturbranche statt. Diese Messe konzentrierte sich auf Innovation und Nachhaltigkeit in den Bereichen Fischgesundheit, sauberere Fischzucht, genetische Selektion und andere Themen.
Umsatz und Prognose des Marktes für Fischimpfstoffe in Europa bis 2030 (in Mio. US-Dollar)
Marktsegmentierung für Fischimpfstoffe in Europa
Der Markt für Fischimpfstoffe in Europa ist nach Impfstofftyp und Anwendung segmentiert , Verabreichungsweg, Art und Land.
Basierend auf dem Impfstofftyp ist der europäische Fischimpfstoffmarkt in inaktivierte Impfstoffe, abgeschwächte Lebendimpfstoffe, Untereinheitenimpfstoffe, rekombinante Vektorimpfstoffe und andere unterteilt. Das Segment der inaktivierten Impfstoffe hatte im Jahr 2022 den größten Marktanteil.
Je nach Anwendung ist der europäische Markt für Fischimpfstoffe in bakterielle Infektionen, virale Infektionen und parasitäre Infektionen unterteilt. Das Segment der bakteriellen Infektionen hatte im Jahr 2022 den größten Marktanteil.
Basierend auf dem Verabreichungsweg ist der europäische Markt für Fischimpfstoffe in Injektionsimpfstoffe, Immersionsimpfstoffe und orale Impfstoffe unterteilt. Das Segment der Injektionsimpfstoffe hatte im Jahr 2022 den größten Marktanteil.
Basierend auf der Art ist der europäische Markt für Fischimpfstoffe in Lachs, Forelle, Tilapia und andere unterteilt. Das Lachssegment hatte im Jahr 2022 den größten Marktanteil.
Je nach Land ist der europäische Markt für Fischimpfstoffe in das Vereinigte Königreich, Deutschland, Frankreich, Italien, Spanien und das übrige Europa unterteilt. Das Vereinigte Königreich dominierte im Jahr 2022 den Marktanteil von Fischimpfstoffen in Europa.
Elanco Animal Health Inc, Hipra SA, Merck & Co Inc., Phibro Animal Health Corp, Vaxxinova International BV und Zoetis Inc. gehören zu den führenden Unternehmen Unternehmen, die auf dem europäischen Markt für Fischimpfstoffe tätig sind.
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Europe Fish Vaccine Market
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Fish Vaccine Market - Key Industry Dynamics
4.1 Market Drivers:
4.1.1 Government Initiatives to Develop Aquaculture Industry
4.1.2 Surging Demand for Aquatic Animal-Derived Food Products
4.2 Market Restraints
4.2.1 Stringent Regulations for Approval of Vaccine
4.3 Market Opportunities
4.3.1 Development of Novel Fish Vaccine
4.4 Future Trends
4.4.1 Technological Advancements in Fish Vaccine
4.5 Impact Analysis:
5. Fish Vaccine Market - Europe Market Analysis
5.1 Fish Vaccine Market Revenue (US$ Th), 2022 - 2030
6. Europe Fish Vaccine Market - Revenue and Forecast to 2030 - by Vaccine Type
6.1 Overview
6.2 Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
6.3 Inactivated Vaccines
6.3.1 Overview
6.3.2 Inactivated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
6.4 Live Attenuated Vaccines
6.4.1 Overview
6.4.2 Live Attenuated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
6.5 Subunit Vaccines
6.5.1 Overview
6.5.2 Subunit Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
6.6 Recombinant Vector Vaccine
6.6.1 Overview
6.6.2 Recombinant Vector Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
6.7 Others
6.7.1 Overview
6.7.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
7. Europe Fish Vaccine Market - Revenue and Forecast to 2030 - by Application
7.1 Overview
7.2 Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
7.3 Bacterial Infection
7.3.1 Overview
7.3.2 Bacterial Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
7.4 Viral Infection
7.4.1 Overview
7.4.2 Viral Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
7.5 Parasitic
7.5.1 Overview
7.5.2 Parasitic: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
8. Europe Fish Vaccine Market - Revenue and Forecast to 2030 - by Route of Administration
8.1 Overview
8.2 Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
8.3 Injection vaccine
8.3.1 Overview
8.3.2 Injection vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
8.4 Immersion Vaccine
8.4.1 Overview
8.4.2 Immersion Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
8.5 Oral Vaccine
8.5.1 Overview
8.5.2 Oral Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
9. Europe Fish Vaccine Market - Revenue and Forecast to 2030 - by Species
9.1 Overview
9.2 Fish Vaccine Market Revenue Share, by Species, 2022 & 2030 (%)
9.3 Salmon
9.3.1 Overview
9.3.2 Salmon: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
9.4 Trout
9.4.1 Overview
9.4.2 Trout: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
9.5 Tilapia
9.5.1 Overview
9.5.2 Tilapia: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
9.6 Others
9.6.1 Overview
9.6.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
10. Europe Fish Vaccine Market - Country Analysis
10.1 Europe Fish Vaccine Market, Revenue and Forecast to 2030
10.1.1 Overview
10.1.2 Europe Fish Vaccine Market, by Country
10.1.2.1 UK
10.1.2.1.1 Overview
10.1.2.1.2 UK Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.1.3 UK: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.1.4 UK: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.1.5 UK: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.1.6 UK: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.2.2 Germany
10.1.2.2.1 Overview
10.1.2.2.2 Germany Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.2.3 Germany: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.2.4 Germany: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.2.5 Germany: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.2.6 Germany: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.2.3 France
10.1.2.3.1 Overview
10.1.2.3.2 France Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.3.3 France: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.3.4 France: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.3.5 France: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.3.6 France: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.2.4 Italy
10.1.2.4.1 Overview
10.1.2.4.2 Italy Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.4.3 Italy: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.4.4 Italy: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.4.5 Italy: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.4.6 Italy: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.2.5 Spain
10.1.2.5.1 Overview
10.1.2.5.2 Spain Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.5.3 Spain: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.5.4 Spain: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.5.5 Spain: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.5.6 Spain: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.2.6 Rest of Europe
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Europe Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.6.3 Rest of Europe: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.6.4 Rest of Europe: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.6.5 Rest of Europe: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.6.6 Rest of Europe: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
11. Fish Vaccine Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies in Fish Vaccine Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Zoetis Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Merck & Co Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 HIPRA SA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Phibro Animal Health Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Vaxxinova International BV
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Elanco Animal Health Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
List of Tables
Table 1. Europe Fish Vaccine Market Segmentation
Table 2. Worldwide Fish Production and Consumption in 2022
Table 3. Major Bacterial Diseases in Fish
Table 4. Major Viral Diseases in Fish
Table 5. Major Parasitic Diseases in Fish
Table 6. Atlantic Salmon Production 2020
Table 7. UK Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
Table 8. UK Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
Table 9. UK Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
Table 10. UK Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
Table 11. Germany Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
Table 12. Germany Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
Table 13. Germany Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
Table 14. Germany Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
Table 15. France Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
Table 16. France Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
Table 17. France Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
Table 18. France Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
Table 19. Italy Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
Table 20. Italy Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
Table 21. Italy Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
Table 22. Italy Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
Table 23. Spain Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
Table 24. Spain Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
Table 25. Spain Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
Table 26. Spain Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
Table 27. Rest of Europe Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
Table 28. Rest of Europe Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
Table 29. Rest of Europe Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
Table 30. Rest of Europe Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
Table 31. Recent Inorganic Growth Strategies in the Fish Vaccine Market
Table 32. Recent Organic Growth Strategies in Fish Vaccine Market
Table 33. Glossary of Terms, Fish Vaccine Market
List of Figures
Figure 1. Europe Fish Vaccine Market Segmentation, By Country
Figure 2. Europe Fish Vaccine Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Fish Vaccine Market Revenue (US$ Th), 2022 - 2030
Figure 5. Europe Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
Figure 6. Inactivated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 7. Live Attenuated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 8. Subunit Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 9. Recombinant Vector Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 10. Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 11. Europe Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
Figure 12. Bacterial Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 13. Viral Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 14. Parasitic: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 15. Europe Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
Figure 16. Injected: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 17. Immersion Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 18. Oral Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 19. Fish Vaccine Market Revenue Share, Species, 2022 & 2030 (%)
Figure 20. Salmon: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 21. Trout: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 22. Tilapia: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 23. Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 24. Europe Fish Vaccine Market, by Key Country - Revenue, 2022 (US$ Thousand)
Figure 25. Europe Fish Vaccine Market, By Key Countries, 2022 and 2030 (%)
Figure 26. UK Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 27. Germany Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 28. France Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 29. Italy Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 30. Spain Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 31. Rest of Europe Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 32. Growth Strategies in Fish Vaccine Market
1. Elanco Animal Health Inc
2. Hipra SA
3. Merck & Co Inc.
4. Phibro Animal Health Corp
5. Vaxxinova International BV
6. Zoetis Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe fish vaccines market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe fish vaccines market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe fish vaccines market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution